Stephens Inc’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.19M | Buy |
24,925
+500
| +2% | +$21.5K | 0.01% | 631 |
|
|
2026
Q1 | $898K | Sell |
24,425
-5,521
| -18% | -$262K | 0.01% | 670 |
|
|
2025
Q4 | $1.52M | Buy |
29,946
+4,818
| +19% | +$246K | 0.02% | 531 |
|
|
2025
Q3 | $1.39M | Sell |
25,128
-125,281
| -83% | -$7.33M | 0.02% | 562 |
|
|
2025
Q2 | $11.1M | Buy |
150,409
+2,721
| +2% | +$185K | 0.15% | 147 |
|
|
2025
Q1 | $10.3M | Buy |
147,688
+44,270
| +43% | +$3.66M | 0.15% | 150 |
|
|
2024
Q4 | $8.9M | Sell |
103,418
-55,463
| -35% | -$6M | 0.12% | 171 |
|
|
2024
Q3 | $18.9M | Buy |
158,881
+37,585
| +31% | +$5.01M | 0.27% | 90 |
|
|
2024
Q2 | $17.3M | Buy |
121,296
+23,934
| +25% | +$3.17M | 0.26% | 90 |
|
|
2024
Q1 | $12.5M | Buy |
97,362
+28,116
| +41% | +$3.35M | 0.19% | 132 |
|
|
2023
Q4 | $7.16M | Buy |
69,246
+4,245
| +7% | +$420K | 0.12% | 188 |
|
|
2023
Q3 | $5.91M | Sell |
65,001
-3,437
| -5% | -$303K | 0.11% | 203 |
|
|
2023
Q2 | $5.54M | Sell |
68,438
-9,066
| -12% | -$741K | 0.1% | 217 |
|
|
2023
Q1 | $6.17M | Buy |
77,504
+12,628
| +19% | +$895K | 0.12% | 192 |
|
|
2022
Q4 | $4.39M | Sell |
64,876
-1,276
| -2% | -$74.8K | 0.09% | 228 |
|
|
2022
Q3 | $3.29M | Buy |
66,152
+2,884
| +5% | +$154K | 0.07% | 276 |
|
|
2022
Q2 | $3.52M | Sell |
63,268
-286
| -0.5% | -$15.9K | 0.07% | 276 |
|
|
2022
Q1 | $3.53M | Sell |
63,554
-2,680
| -4% | -$138K | 0.06% | 322 |
|
|
2021
Q4 | $3.71M | Sell |
66,234
-2,372
| -3% | -$129K | 0.06% | 332 |
|
|
2021
Q3 | $3.29M | Sell |
68,606
-64,084
| -48% | -$3.1M | 0.05% | 357 |
|
|
2021
Q2 | $5.56M | Buy |
132,690
+46,750
| +54% | +$1.81M | 0.08% | 247 |
|
|
2021
Q1 | $2.9M | Buy |
85,940
+18,196
| +27% | +$648K | 0.05% | 370 |
|
|
2020
Q4 | $2.37M | Buy |
67,744
+2,158
| +3% | +$74.6K | 0.04% | 385 |
|
|
2020
Q3 | $2.28M | Buy |
65,586
+502
| +0.8% | +$16.7K | 0.04% | 366 |
|
|
2020
Q2 | $2.13M | Sell |
65,084
-32,292
| -33% | -$1.03M | 0.05% | 364 |
|
|
2020
Q1 | $2.93M | Buy |
97,376
+2,206
| +2% | +$65.7K | 0.08% | 266 |
|
|
2019
Q4 | $2.75M | Buy |
95,170
+4,796
| +5% | +$133K | 0.06% | 330 |
|
|
2019
Q3 | $2.34M | Buy |
90,374
+2,720
| +3% | +$68.8K | 0.05% | 353 |
|
|
2019
Q2 | $2.24M | Buy |
87,654
+7,262
| +9% | +$179K | 0.05% | 385 |
|
|
2019
Q1 | $2.1M | Buy |
80,392
+7,514
| +10% | +$185K | 0.05% | 387 |
|
|
2018
Q4 | $1.68M | Buy |
72,878
+5,114
| +8% | +$114K | 0.05% | 402 |
|
|
2018
Q3 | $1.6M | Buy |
+67,764
| New | +$1.65M | 0.04% | 452 |
|
|
2017
Q3 | – | Sell |
-89,286
| Closed | -$1.92M | – | 820 |
|
|
2017
Q2 | $1.92M | Buy |
89,286
+19,456
| +28% | +$393K | 0.07% | 297 |
|
|
2017
Q1 | $1.2M | Buy |
69,830
+42,306
| +154% | +$737K | 0.04% | 378 |
|
|
2016
Q4 | $494K | Buy |
+27,524
| New | +$499K | 0.02% | 493 |
|
Other funds holding NVO
F
Stephens Inc's NVO Position: Q2 2026 in Review
Stephens Inc increased its Novo Nordisk (NVO) stake by 2% in Q2 2026, buying an estimated $21.5K and bringing the position to 24,925 shares worth $1.19M. The position accounts for 0.01% of the portfolio, ranked #631.
Stephens Inc first reported a position in NVO in Q4 2016 and has held it in 35 quarters since. The position peaked at $18.9M in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Stephens Inc held 24,925 shares of Novo Nordisk worth $1.19M as of Q2 2026.
- Stephens Inc bought 500 Novo Nordisk shares in Q2 2026, an estimated $21.5K.
- Novo Nordisk made up 0.01% of Stephens Inc's portfolio in Q2 2026, its #631 holding.
- Stephens Inc first reported a position in Novo Nordisk in Q4 2016 and has held it in 35 quarters since.
- Stephens Inc's Novo Nordisk position peaked at $18.9M in Q3 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.